MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • 2024 International Congress

    Exercise Mitigates DNA Methylation Changes at cg17274742 Associated with the Circadian Gene Variant PER2 rs2304672: A Biobank Analysis

    YC. Chen, SL. Wu, YP. Liaw (Changhua, Taiwan)

    Objective: This research aims to dissect the influence of physical activity and circadian rhythms on neuroinflammation and neurodegenerative disease progression, focusing on Parkinson's Disease (PD).…
  • 2024 International Congress

    Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes

    J. Salimjonov, N. Rashidova, KH. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: This study investigates the impact of COVID-19 vaccination on levels of interleukin 6 (IL-6) and brain-derived neurotrophic factor (BDNF) in patients with Parkinson's disease…
  • 2024 International Congress

    Single cell transcriptomics of peripheral blood mononuclear cells and associations with clinical outcomes in Parkinson’s disease

    J. Wallin, B. Yaghmaeian Salmani, K. Tiklova, L. Gillberg, H. Green, T. Perlmann, P. Svenningsson (Solna, Sweden)

    Objective: To assess transcriptomics signatures for monocytes and T-cells in different stages of Parkinson’s disease (PD) compared to controls and possible correlations with clinical outcomes.…
  • 2023 International Congress

    Baseline fluid biomarkers in a phase 2 clinical trial in Parkinson’s Disease

    T. Kustermann, G. Pagano, H. Svoboda, T. Nikolcheva, K. Taylor (Basel, Switzerland)

    Objective: To evaluate baseline CSF and blood-based biomarkers of pathology in early-stage Parkinson’s Disease (PD) participants in the phase 2 clinical trial PASADENA. Background: Observational…
  • 2023 International Congress

    GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase shows evidence of pharmacological efficacy in an animal model of Parkinson’s disease.

    B. Calvo-Flores Guzman, N. Perez-Carmona, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, J. Taylor (Lugano, Switzerland)

    Objective: To investigate the effect of the structurally targeted allosteric regulator GT-02287 on rotenone-induced neurotoxic effects in a Parkinson’s disease animal model. Background: Mutations in…
  • 2023 International Congress

    Axial impairment and bradykinesia are related to increased CSF sTREM2, a neuroinflammation biomarker, in Parkinson’s disease

    A. Brück, R. Ajalin, H. Al-Abdulrasul, H. Zetterberg, K. Blennow, E. Löyttyniemi, J. Rinne (Turku, Finland)

    Objective: To explore the association between Parkinson’s disease (PD) motor symptoms and CSF biomarkers for neuroinflammation and neurodegeneration. Background: Previous in vivo and post mortem…
  • 2023 International Congress

    Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

    D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)

    Objective: To explore the antioxidant and anti-inflammatory role of Carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model Background: NLRP3 inflammasome mediated neuroinflammation is…
  • 2023 International Congress

    RNA editing contributes to the inflammatory astrocytic response in Parkinson’s disease.

    A. Wagen, K. D'Sa, M. Choi, S. Strohbuecker, G. Young, R. Reynolds, S. Garcia-Ruiz, Z. Chen, A. Ghareeb, J. Bayne, S. Rodriques, M. Horrocks, S. Gandhi, M. Ryten (London, United Kingdom)

    Objective: 1) Using an IPSC derived cell model to explore astrocytic responses alone and cocultured neurons to alpha-synuclein oligomer (αsynO) treatment.2) Determine the extent to…
  • 2023 International Congress

    The Role of Adaptive Immunity caused by α-synuclein Recognition Specific Sequence Peptide on the Onset of Parkinson’s Disease Pathogenesis

    MG. Jo, BN. Lee, HM. Seong, SH. Kim, HN. Choi, MG. Kim, SP. Yun (Jinju, Republic of Korea)

    Objective: We investigated whether α-synuclein-derived peptides (recognized specific sequence in α-synuclein) can drive T-cell response and evaluated the neurotoxicity of α-synuclein peptide-specific T-cell in Parkinson’s…
  • 2023 International Congress

    Non-invasive Vagus Nerve Stimulation Alters Molecular Markers in Parkinson’s Disease Patients with Freezing of Gait

    R. Banerjee, B. Mondal, S. Choudhury, A. Roy, K. Chatterjee, P. Basu, S. Baker, M. Baker, H. Kumar (Kolkata, India)

    Objective: To investigate molecular mechanisms underlying non-invasive vagus nerve stimulation (nVNS) in Parkinson’s disease (PD) patients with freezing of gait (FOG). Background: FOG remains one…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley